Page last updated: 2024-10-28

glyburide and Intermittent Claudication

glyburide has been researched along with Intermittent Claudication in 1 studies

Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.

Intermittent Claudication: A symptom complex characterized by pain and weakness in SKELETAL MUSCLE group associated with exercise, such as leg pain and weakness brought on by walking. Such muscle limpness disappears after a brief rest and is often relates to arterial STENOSIS; muscle ISCHEMIA; and accumulation of LACTATE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mortensen, UM1
Nielsen-Kudsk, JE1
Sondergaard, HM1
Jakobsen, P1
Jensen, BS1
Schmitz, O1
Nielsen, TT1

Trials

1 trial available for glyburide and Intermittent Claudication

ArticleYear
Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Diabetic medicine : a journal of the British Diabetic Association, 2006, Volume: 23, Issue:3

    Topics: Adenosine Triphosphate; Administration, Oral; Aged; Blood Glucose; Blood Pressure; Cross-Over Studie

2006